Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vhk | BPK | Vascular endothelial growth factor receptor 2 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3vhk | BPK | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 1.000 | |
| 4ase | AV9 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.666 | |
| 3efl | 706 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.607 | |
| 3hng | 8ST | Vascular endothelial growth factor receptor 1 | 2.7.10.1 | 0.590 | |
| 3vnt | 0JA | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.589 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.583 | |
| 3cp9 | C19 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.581 | |
| 2xir | 00J | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.562 | |
| 3dtw | A96 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.552 | |
| 2qu6 | 857 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.551 | |
| 5hi2 | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.542 | |
| 4agw | NG7 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.539 | |
| 2hyy | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.538 | |
| 2p2i | 608 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.538 | |
| 4eyj | N61 | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.533 | |
| 4fc0 | 0T2 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.531 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.529 | |
| 4ksp | 1SU | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.526 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.521 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.519 | |
| 1iep | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.516 | |
| 3hv5 | R24 | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 3kq7 | KQ7 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.488 | |
| 3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.486 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.484 | |
| 4a84 | DXC | Major pollen allergen Bet v 1-A | / | 0.482 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.482 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.475 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.475 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.473 | |
| 2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.465 | |
| 3k9v | CPS | 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | / | 0.465 | |
| 3e8n | VRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.464 | |
| 3os3 | 3OS | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.464 | |
| 4l9q | 9TP | Serum albumin | / | 0.461 | |
| 3iw8 | HIZ | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 2dte | NAI | Glucose 1-dehydrogenase related protein | / | 0.454 | |
| 2o3z | AI7 | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.454 | |
| 3lfb | Z87 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 5fkn | TDC | Tetracycline repressor protein class D | / | 0.453 | |
| 1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
| 2y01 | Y01 | Beta-1 adrenergic receptor | / | 0.450 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.446 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.445 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.442 | |
| 3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.442 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 4at5 | MUJ | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.441 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
| 4qe6 | JN3 | Bile acid receptor | / | 0.440 |